Menopause Insomnia Medication: Sleep Aids and Treatments Compared

What is the best menopause insomnia medication?

If you are lying awake at 3 a.m. searching for menopause insomnia medication, the most useful first question is what is waking you. Night sweats and hot flashes are a common cause, but menopause can also bring insomnia that continues even when hot flashes are under control, along with anxiety, a full bladder or sleep apnea. The right treatment depends on which of these is driving it.

In broad terms, the options fall into four groups:

• CBT-I, a structured, short course of therapy that is the recommended first treatment for chronic insomnia.
• Treatments for hot flashes, including hormone therapy and several non-hormonal medicines, which help sleep when night sweats are the cause.
• Prescription sleep medicines, such as zolpidem, low-dose doxepin and orexin blockers, for insomnia itself.
• Over-the-counter sleep aids, such as melatonin and antihistamines, which have weak evidence and real downsides.

Our guide to menopause insomnia explains why sleep changes at this stage of life.

Why is CBT-I recommended before sleeping pills?

The American College of Physicians strongly recommends cognitive behavioral therapy for insomnia (CBT-I) as the first treatment for all adults with chronic insomnia, and suggests adding medicine only through shared decision-making if CBT-I alone isn’t enough. CBT-I typically includes sleep scheduling, getting out of bed when you can’t sleep, and working on the thoughts that keep you awake.

It works in menopause specifically. In a trial of 106 women with insomnia and daily hot flashes, six phone sessions of CBT-I cut insomnia scores by 9.9 points, compared with 4.7 points for menopause education. Six months later, 84% of the CBT-I group were out of the insomnia range, compared with 43% of the comparison group. When researchers pooled four trials in women with hot flashes, CBT-I improved insomnia scores more than low-dose estradiol, escitalopram, venlafaxine, yoga or exercise (Guthrie 2018). CBT-I is available through therapists, phone programs and apps.

By the numbers

Phone CBT-I in women with hot flashes

9.9 ptsdrop in insomnia scores with CBT-I, vs 4.7 with menopause educationSource: McCurry 2016

84%of the CBT-I group out of the insomnia range six months laterSource: McCurry 2016

43%of the comparison group out of the insomnia range at six monthsSource: McCurry 2016

Does hormone therapy help menopause insomnia?

When night sweats are breaking up your sleep, hormone therapy is often the most direct fix. The Menopause Society’s 2022 position statement says hormone therapy improves sleep in women with bothersome nighttime hot flashes by reducing awakenings, and that estrogen may have some effect on sleep even apart from hot flashes. It also notes that micronized progesterone 300 mg at night reduced hot flashes and improved sleep compared with placebo. A meta-analysis found progesterone helped people fall asleep faster but did not lengthen total sleep. Our guides to progesterone and sleep and hormone replacement therapy cover benefits and risks.

Amie HRT+ is one prescription option for women whose sleep is disrupted by menopause symptoms. It is a single compounded cream with estradiol and progesterone, at a strength chosen by a licensed clinician after an online review. It is compounded and not FDA-approved; FDA-approved estradiol and progesterone products are also available. Hormone therapy isn’t right for everyone, especially women with a history of breast cancer, blood clots or stroke, and a clinician decides whether it is appropriate for you.

Which non-hormonal medicines help sleep disrupted by hot flashes?

For women who can’t or don’t want to use hormones, several medicines reduce hot flashes. The Menopause Society’s 2023 nonhormone statement recommends SSRIs and SNRIs, gabapentin and fezolinetant based on good-quality evidence.

Low-dose paroxetine (Brisdelle)

Brisdelle is paroxetine 7.5 mg taken at bedtime, FDA-approved for moderate to severe hot flashes due to menopause. It is a lower dose than is used for depression and is not approved for any psychiatric condition. Like all antidepressants, it carries a boxed warning about suicidal thoughts, and the label warns it may reduce the effectiveness of tamoxifen, so tell your clinician if you take tamoxifen for breast cancer.

Gabapentin

Gabapentin is used off-label for hot flashes. A meta-analysis of 21 trials found it reduced hot flash frequency compared with placebo, though less than estrogen. Dizziness and sleepiness were several times more common than with placebo.

Fezolinetant (Veozah)

Veozah is a once-daily pill that blocks a brain signal (neurokinin 3) involved in temperature control. It is FDA-approved for moderate to severe hot flashes due to menopause. Its label carries a boxed warning for liver injury and requires liver blood tests before starting and regularly during the first nine months.

Elinzanetant (Lynkuet)

Lynkuet was FDA-approved in 2025 for moderate to severe hot flashes due to menopause. It blocks two related signals (neurokinin 1 and 3) and is taken as 120 mg once daily at bedtime. In the OASIS 1 and 2 trials, it reduced hot flash frequency and improved sleep disturbance scores at 12 weeks compared with placebo. Its label lists sleepiness, fatigue and dizziness as common, with nervous system effects in 11.9% of women versus 3.5% on placebo, so you shouldn’t drive if it makes you drowsy. Liver tests are needed before starting, and it must not be used in pregnancy.

What about prescription sleeping pills?

If insomnia continues after CBT-I and after hot flashes are treated, a sleep medicine may help in the short term. The American Academy of Sleep Medicine’s guideline gives weak recommendations for several, based on modest benefits in trials:

• Z-drugs (zolpidem, eszopiclone, zaleplon). These help you fall asleep or stay asleep. They carry a boxed warning for complex sleep behaviors such as sleepwalking and sleep-driving, which can cause serious injury. Women clear zolpidem more slowly than men, so the Ambien label sets a starting dose of 5 mg for women.
• Low-dose doxepin. Silenor is doxepin at 3 to 6 mg, far below antidepressant doses, approved for trouble staying asleep.
• Orexin receptor antagonists (suvorexant, lemborexant, daridorexant). These block a wakefulness signal and are approved for trouble falling or staying asleep, as on the Belsomra label. Next-day drowsiness is the main concern. The Menopause Society does not recommend suvorexant as a treatment for hot flashes themselves.

The same guideline suggests not using trazodone for insomnia. All sleep medicines can cause next-day impairment and should be combined carefully, if at all, with alcohol, opioids or other sedatives.

Do melatonin and over-the-counter sleep aids work?

Melatonin. The NIH’s complementary health center says there isn’t enough strong evidence to recommend melatonin for chronic insomnia, and the sleep medicine guideline suggests not using it for that purpose. Quality is a problem too: in a test of 31 products, melatonin content ranged from 83% less to 478% more than the label said, and some contained serotonin. Short-term side effects are usually mild, such as headache, dizziness and next-day sleepiness.

Antihistamine sleep aids. Diphenhydramine (in many “PM” products) and doxylamine are sold over the counter, but the guideline suggests not using diphenhydramine for chronic insomnia. They often cause next-day grogginess, and they are strong anticholinergics: in a study of 3,434 adults 65 and older, the heaviest long-term use of these drugs was linked to a 54% higher risk of dementia.

By the numbers

Over-the-counter sleep aid cautions

478%more melatonin than the label said, at the high end of 31 products testedSource: Erland 2017

54%higher dementia risk with the heaviest long-term anticholinergic useSource: Gray 2015

Supplements such as magnesium, valerian and herbal blends have limited evidence; see our article on magnesium for sleep.

Menopause sleep aids compared

When to talk to a clinician about sleep